The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory ...

The advisory panel mostly agreed with the FDA ... kids of immigrants COVID-19 vaccines have saved millions of lives and ...

That data suggested the possibility that the updated booster might not be any more effective at preventing Covid ... the FDA advisers’ meeting, the agency authorized the Moderna bivalent vaccines.

But the FDA believes the time is right for annual shots targeting the latest COVID-19 variants, even though Peter Marks, M.D.

A vaccine safety monitoring system detected a "safety signal" that Pfizer's bivalent booster ... and older stay up to date on their COVID-19 shots. The FDA's Vaccines and Related Biological ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

This safety concern has not been identified with Moderna's (MRNA.O) bivalent shot and both the CDC and FDA continue to recommend ... EU may pay more for Pfizer COVID shots in return for lower ...